| | Combining Lithoclast and ultrasound power in one device for percutaneous nephrolithotomy: in vitro results of a novel and highly effective technologyReceived 15 April 2002; accepted 3 September 2002. Abstract ObjectivesA new device for percutaneous nephrolithotomy, combining Lithoclast (LC) and ultrasound (US) lithotripsy, was developed. Under standardized in vitro conditions, we evaluated the efficacy of the new technique using artificial stones. Combined application of pneumatic and US lithotripsy was compared with each of the two components alone. MethodsFive different artificial stones of defined hardness were used. Disintegration was performed under defined pressure in a water bath. The time until the first fragmentation and until complete disintegration to fragments of 2 mm or smaller was measured for LC and US alone and for combined lithotripsy. Furthermore, the disintegrated partition after 1 minute and time until 50% disintegration of each stone was determined. ResultsWith regard to first fragmentation and complete disintegration, LC and US combination showed superior efficacy. First fragmentation was achieved 25 to 200 times faster and complete disintegration in a range of 11 to 15 minutes. No complete disintegration was possible by LC and US alone within a time limit of 20 minutes. The disintegrated stone mass after 1 minute was 1.5 to 4 times larger in combined lithotripsy and the 50% disintegration time was 30% to 50% compared with LC or US alone. No technical defects occurred. ConclusionsCombining LC and US in one device for percutaneous nephrolithotomy shows promising in vitro results in an artificial stone model. It seems to provide superior efficacy in the disintegration parameters important for clinical practice.
Since shock wave lithotripsy (SWL) pioneered minimal invasive management of kidney and ureteral stones in the 1980s,1 it has become standard therapy for nephrolithiasis, providing reliable disintegration for most kidney stones. In stones larger than 2 cm in diameter or staghorn calculi of the renal pelvis, SWL is often not sufficient. Alternative therapeutic options are open stone surgery or percutaneous endoscopic management. Although intracorporeal lithotripsy and removal of bladder stones by several techniques has an almost 100-year history, percutaneous endoscopic management of nephrolithiasis has emerged only during the past two decades and was directly connected to the development of direct visualization of the upper urinary tract both by ureterorenoscopy and percutaneous nephroscopy/pyeloscopy.2
The electrohydraulic lithotriptor that was originally invented for bladder stone disintegration has also been used in upper tract lithotripsy. It shows satisfactory efficacy in softer stones, with good reduction of fragment size, but its use is limited by a relatively high rate of urothelial lesions or even organ perforations.2, 3, 4 Although refining technology has reduced these adverse effects, it has a lower margin of safety than other modern techniques. Laser lithotripsy, especially the holmium:yttrium-aluminum-garnet laser can provide effective stone disintegration. However, its efficiency can vary with stone composition and its application may be harmful to the organ wall surrounding the stone.2, 5, 6, 7
In ultrasound (US) lithotripsy, piezoelectric energy is transmitted to the stone by a metal probe. The probe tip causes the stone to resonate at high frequency and break. Its advantages are effective disintegration, especially in impacted stones, minimal damage to the surrounding tissue, and the possibility of removing debris by suction through a hollow US probe.2, 3, 8 However, the US technique is restricted to rigid devices, and continuous irrigation is needed to prevent overheating of the probe.
Lithoclast (LC) lithotripsy uses the principle of a pneumatically driven bullet, striking a solid metal rod at a defined frequency. It fragments stones independent of their composition, and multiple clinical trials have shown the technique to be safe and effective.9, 10, 11, 12, 13 It works best with rigid devices, and the equipment is durable and reusable.
The newly developed lithotriptor combines both US and LC lithotripsy within a single instrument. US and LC modes can be applied alone or in combination and most fragments are removed through the hollow US probe.
We evaluated the efficacy of this novel technology under standardized experimental conditions using different artificial stones of defined hardness.
Material and methods  Instrument The new device (Fig. 1) consists of a Lithoclast Master (EMS, Nyon, Switzerland) with probes 0.8, 1.0, and 1.2 mm in diameter. The pulse repetition rate varies from 1 to 12 Hz, and the power of the ballistic impulse is adjustable between 0% and 100%. The second component is a newly developed US handpiece with a 3.3-mm hollow US probe. US energy can be adjusted from 0% to 100% at a frequency of 24 to 26 kHz. The two units are combined, with the LC probe positioned off center in the US tube. The tip of the LC probe is advanced about 1 mm out of the US tube. Suction is applied through the hollow US tube. Control unit Both components of the device are connected to a control unit providing separate display screens for the LC and US lithotriptors. The screens provide the surgeon with information about US power, time of US use, impulse frequency and power of the LC, and the number of pulses since the last power up. A pinch valve directly connected to the control unit regulates suction on the US tube. Foot switch A two-paddle foot switch, one for the LC and one for the US unit, activates the new lithotriptor. The paddles can be activated separately or together. The US switch has a two-step mechanism, activating suction only with step one and suction plus US with step two. To compare the efficacy of the LC, US, and combined application, we performed the following, standardized, in vitro lithotripsy procedure. Five artificial, cube-shaped stones of the same size but of different hardness and density levels (Table I) were used. A 5-L metal bowl was filled with water and a soft textile pad lined the bottom to keep the stone in a stable position while performing disintegration. Three stones of each hardness were evaluated. All stones had the same volume (0.5 cm3). For in vitro disintegration, a 1.0-mm LC probe inside a 3.3-mm US tube was used. For both US and LC, 80% power was used, the impulse frequency of the LC was 6 Hz. This frequency and power setting showed the best clinical results and reliable function of the instrument in our clinical experience. To provide consistent results, one investigator (J.W.) performed all lithotripsy procedures. After placing the stone on the pad inside the water-filled bowl, three stones of one hardness were disintegrated either by LC or US, or combined application. The probe was positioned vertically on the stone or the fragments, respectively. Pressure was applied on the stone only by the weight of the instrument (350 g), with the investigator holding the instrument in position and repositioning it if necessary. The time until the first fragmentation of each stone and the time until complete disintegration, defined as all fragments evacuated by suction through the US tube (ie, smaller than 2.2 mm), were measured. Furthermore, the percentage of stone mass disintegrated after 1 minute was determined. By weighing the disintegrated partition of the stone every 30 seconds, the 50% disintegration time was evaluated. Statistical analysis Three stones of each hardness were disintegrated. To compare the different lithotripsy techniques, statistical analysis was performed on the following parameters: the time until first fragmentation for all stones, percentage of disintegration after 1 minute for all stones, and time until 50% disintegration for the Moldabaster, Moldano, and Fuji Rock White stones. Because of the limited number of experiments, the normal distribution of the determined values cannot be assumed; thus, we chose nonparametric Mann-Whitney U test statistics. Statistical calculations were performed using commercially available computer software (Statistical Package for Social Sciences, version 10.1).
Results  The efficacy of the combination device was compared with LC and US alone. The time until first stone fragmentation and until disintegration of the complete stone mass to fragments small enough for evacuation through the US tube was measured. The combined application of US and LC had a 25 to 200-fold shorter time until first stone fragmentation that was statistically significant for all stones (Table I). Complete disintegration was achieved by US and LC combination in 298 and 295 seconds in the softest and hardest stones, respectively and in 660, 760, and 990 seconds in medium-hard stones. With neither US nor LC disintegration alone could we achieve complete disintegration within a 20-minute time limit (Table I). After 1 minute, the disintegrated stone mass was 1.5 to 4 times larger with the combined application of US and LC compared with US or LC lithotripsy alone. The difference reached the level of significance for three of five tested stone materials. The time until 50% disintegration was significantly shorter with combined lithotripsy compared with separate activation (Table II). The lithotripsy procedures were performed on 3 consecutive days for 3 to 6 hours and with almost continuous activation of at least one of the instrument’s components. No technical defect in the probes, US generator, pneumatic lithotriptor, control unit, or foot switch ensued. All experiments (disintegration of 45 stones of 0.5 cm3) were performed using the same US tube and LC probe.
Comment  Therapeutic management of urolithiasis has been revolutionized by the development of extracorporeal and intracorporeal lithotripsy. Different techniques of stone disintegration, a direct approach to the stone under direct visualization of the urinary tract, and auxiliary modalities such as ureteral stenting and percutaneous nephrostomy have reduced the need for open stone surgery. Before evaluating different intracorporeal and extracorporeal lithotripsy techniques in clinical practice, the disintegration efficacy, safety, and reproducibility have to be tested in artificial stones under defined in vitro conditions. The physics, microhardness, and comparability of natural and artificially produced stones and the importance of artificial stones for experimental models of extracorporeal and intracorporeal lithotripsy have been demonstrated.14, 15 By special fabrication techniques, artificial stones have become comparable to their natural counterparts, and the physical events resulting in fragmentation and finally disintegration of the stones seem to be similar.16, 17 Earlier experimental work on SWL could prove the important role of microfragmentation and cavitational activity for effective stone disintegration.18, 19 Although a number of reports on in vitro or phantom lithotripsy in SWL have been published, experimental work on the different techniques of direct stone disintegration is limited.20, 21, 22, 23 Teh et al.12 compared electrohydraulic, pneumatic, and US lithotripsy in a stone phantom model, as well as in a porcine model, judging the LC technique as effective and clinically safe. In their model, as in our studies, a stone fragment size of 2 mm was used to define successful disintegration. Animal experiments concerning the safety of the LC technique showed no acute or long-term harmful effects to the surrounding tissue, especially compared with electrohydraulic and laser lithotripsy.22, 24 In our experimental model, we tried to create reproducible conditions to compare the efficacy of two established lithotripsy techniques with the newly developed combination of both. Systemic mistakes were eliminated by using standardized artificial stones of defined volume, size, and hardness, defining pressure on the stone at 350g, which seems to be in the range of that used in percutaneous lithotripsy. One investigator performed all lithotripsy procedures. To our knowledge, no in vitro comparison of pneumatic and US lithotripsy has been done other than the work of Teh and coworkers12 who showed the LC to be superior. From our own clinical experience, we had the impression that the LC might be more efficient in harder stones, and US lithotripsy might have advantages in softer stones because of the possibility to evacuate debris, small fragments, and sludge immediately. With the new US and LC probes, these properties stay the same. Combined lithotripsy also fragments hard and soft stones more effectively than those of intermediate hardness. Neither US nor LC was able to achieve complete disintegration within 20 minutes of continuous activation. US showed the best results in all investigated parameters in the softer stones. LC seems to be highly effective in very soft and very hard stones. A synergistic effect in combining both techniques can be found in calculi otherwise difficult to fragment.
Conclusions  Combining LC and US in one device for percutaneous nephrolithotomy shows promising in vitro results in an artificial stone model. The novel technology seems to provide superior efficacy in disintegration parameters important for clinical practice, especially the time to first fragmentation, the time to complete disintegration, and small particle size. All artificial stones could be disintegrated completely, independent of their composition and hardness. Acknowledgements  To Gerald Haupt, M.D. (Cologne, Germany) for friendly support and for providing us with the artificial stones. References  1.
1
Chaussy C, Schmiedt E, Jocham D, et al.
First clinical experience with extracorporeally induced destruction of kidney stones by shock waves.
J Urol. 1982;127:417–420. MEDLINE 2.
2
Grocela JA, Dretler SP.
Intracorporeal lithotripsy.
Urol Clin North Am. 1997;24:13–23. Abstract | Full Text |
Full-Text PDF (878 KB)
|
CrossRef
3.
3
Huffman JL: Ureteroscopy, in Walsh PC, Retik, AB, Vaughan ED, et al (Eds): Campbell’s Urology, 7th ed. Philadelphia, WB Saunders, 1998, vol 3, pp 2776–2777 4.
4
Denstedt JD, Clayman RV.
Electrohydraulic lithotripsy of renal and ureteral calculi.
J Urol. 1990;143:13–17. MEDLINE 5.
5
Dretler SP.
An evaluation of ureteral laser lithotripsy (225 consecutive patients).
J Urol. 1990;143:267–272. MEDLINE 6.
6
Fossion LM, Bogaert GA, Goethuys HJ, et al.
Preliminary experience with the holmium YAG laser in the treatment of soft tissues and cystine stones in children.
Ann Urol. 1999;33:320–327. 7.
7
Teichmann JM, Vassar GJ, Glickman RD, et al.
Ho YAG lithotripsy efficiency varies with stone composition.
Urology. 1998;52:392–397. Abstract | Full Text |
Full-Text PDF (123 KB)
|
CrossRef
8.
8
Fuch G.
Ultrasonic lithotripsy in the ureter.
Urol Clin North Am. 1988;15:347–352. MEDLINE 9.
9
Chaabouni MN, Mhiri MN, Teillac P, et al.
The role of Lithoclast in the endourologic treatment of urinary calculi.
Ann Urol. 1994;28:79–83. 10.
10
Wadhwa SN, Hemal AK, Sharma RK.
Intracorporeal lithotripsy with the Swiss Lithoclast.
Br J Urol. 1994;74:699–702. MEDLINE |
CrossRef
11.
11
Denstedt JD.
Use of Swiss Lithoclast for percutaneous nephrolithotripsy.
J Endourol. 1993;7:477–480. MEDLINE |
CrossRef
12.
12
Teh CL, Zhong P, Preminger GM.
Laboratory and clinical assessment of pneumatically driven intracorporeal lithotripsy.
J Endourol. 1998;12:163–169. MEDLINE |
CrossRef
13.
13
Hofmann R, Pickl U, Hartung R.
The Lithoclast Master®—an improved mechanic lithotriptor.
J Urol. 1996;155(A):331. 14.
14
Heimbach D, Munver R, Zhong P, et al.
Acoustic and mechanical properties of artificial stones in comparison to natural kidney stones.
J Urol. 2000;164:537–544. Abstract | Full Text |
Full-Text PDF (1495 KB)
|
CrossRef
15.
15
Chuong CJ, Zhong P, Preminger GM.
Acoustic and mechanical properties of renal calculi (implications in shock wave lithotripsy).
J Endourol. 1993;7:437–444. MEDLINE |
CrossRef
16.
16
Heimbach D, Jacobs D, Winter P, et al.
Production of artificial urinary stones from natural materials and their physical properties (first results).
Scand J Urol Nephrol. 1997;31:9–13. MEDLINE |
CrossRef
17.
17
Eisenmenger W.
The mechanisms of stone fragmentation in ESWL.
Ultrasound Med Biol. 2001;27:683–693. Abstract | Full Text |
Full-Text PDF (914 KB)
|
CrossRef
18.
18
Sass W, Dreyer HP, Kettermann S, et al.
The role of cavitational activity in fragmentation processes by ESWL.
J Stone Dis. 1992;4:193–207. MEDLINE 19.
19
Sass W, Steffen K, Matura E, et al.
Experiences with lithotriptors (measurements of standardized fragmentation).
J Stone Dis. 1992;4:129–140. MEDLINE 20.
20
Haupt G, van Ophoven A, Pennek J, et al.
In vitro comparison of two ballistic systems for endoscopic stone disintegration.
J Endourol. 1996;10:417–420. MEDLINE |
CrossRef
21.
21
von Niedernhausern W.
Problems in the clinical evaluation of an endoscopic lithotriptor (the case of the Lithoclast® EMS).
Ann Urol. 1994;28:84–89. 22.
22
Piergiovanni M, Desgrandschamps F, Cochand-Priollet B, et al.
Ureteral and bladder lesions after ballistic, ultrasonic, electrohydraulic or laser lithotripsy.
J Endourol. 1994;8:293–299. MEDLINE |
CrossRef
23.
23
Rudhart M, Hirth A.
Use of absorbent in laser lithotripsy with dye lasers (in vitro fragmentation efficiency and jet formation).
J Urol. 1994;152:1005–1008. MEDLINE 24.
24
Denstedt JD, Razvi HA, Rowe E, et al.
Investigation of the tissue effect of a new device for intracorporeal lithotripsy—the Swiss Lithoclast®.
J Urol. 1995;153:535–537. Abstract | Full Text |
Full-Text PDF (1081 KB)
|
CrossRef
a Department of Urology and Pediatric Urology, Philipps-Universität, Marburg, Medical School, Marburg, Germany Reprint requests: Peter Olbert, M.D., Department of Urology and Pediatric Urology, Philipps Universität, Marburg, Medical School, Baldingerstrasse, Marburg 35043, Germany
PII: S0090-4295(02)02256-2 © 2003 Elsevier Science Inc. All rights reserved. | |
|